Privacy Policy
NomosLogic Master Policy Agreement
Effective Date: January 1, 2026 · Version 1.0
1. Data Privacy & Sovereign Ownership
You remain the sole owner of your raw genetic data (SNPs) and metabolic biomarkers. NomosLogic acts as a data custodian with no ownership claims.
We do not, and will never, sell, lease, or rent individual-level health data to pharmaceutical companies, insurance providers, or third-party advertisers without explicit opt-in.
Upon deletion, identifiable genetic data is purged within thirty days per the Delaware Personal Data Privacy Act.
2. HIPAA & Security Standards
All data is encrypted with AES-256 at rest and TLS 1.2+ in transit. Data used for system improvement is stripped of PII and assigned non-referential UUIDs.
NomosLogic voluntarily adheres to HIPAA Security and Privacy Rules for Protected Health Information.
3. Medical Disclaimers & Use of AI
The platform provides Actionable Intelligence for wellness purposes. It does not constitute medical diagnoses or treatment recommendations. Use does not establish a professional health relationship.
Users must consult licensed physicians before making changes to diet, medication, or exercise based on platform findings.
4. Data Usage & Ingestion
Uploading lab PDFs or connecting EHR authorizes Biomarker Analysis Module parsing. Wearable connections (Apple Health, Oura) are optional and revocable through settings.
5. Limitation of Liability & Indemnity
NomosLogic is not liable for indirect, incidental, or consequential damages arising from platform use. Users indemnify the company from claims arising from agreement breach or misuse.
6. Mandatory Arbitration & Class Action Waiver
Disputes shall be resolved through binding arbitration in Salt Lake City, Utah or Wilmington, Delaware. Users waive the right to participate in class-action lawsuits or class-wide arbitration.
7. Governing Law
This agreement is governed by the laws of the State of Delaware without regard to conflict of law principles.